South Wales, Sept. 7 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "IMMUTRIN" on Aug. 24. The details about the trademark application no. UK00004435010 published in the journal no. 2026/036 (Sept. 4).
With Kilburn & Strode LLP as representative, Immutrin Ltd filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations; biopharmaceutical preparations; pharmaceutical preparations for use in the treatment of systemic amyloidosis; pharmaceutical preparations for use in the treatment of cardiovascular disease; antibody preparations for medical purposes; pharmaceutical preparations for the treatment and prevention of rare and genetic diseases; antibodies.
Class 42 : Scientific and medical research and development in the field of pharmaceuticals; scientific and medical research and development in the field of biotechnology; scientific and medical research and development in the field of immunotherapy; scientific and medical research and development in the field of antibody technology; scientific and medical research in the field of rare and genetic diseases; research and development of pharmaceutical products; drug discovery and development services; biotechnology testing; testing of pharmaceuticals; conducting clinical trials; information, advice and consultancy services in relation to all the aforesaid services.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004435010
Disclaimer: Curated by HT Syndication.
